SCHEMBL6599659

SCHEMBL6599659

CCOC(=O)C(CC(C)=O)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.42
TDP1 Q9NUW8 3/20 0.42
HSD17B10 Q99714 2/20 0.42
LMNA P02545 1/20 0.42
ALOX15 P16050 3/20 0.36
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SOAT1 P35610 1/20 0.36
HPGD P15428 2/20 0.35
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
KMT2A Q03164 1/20 0.34
TRPA1 O75762 1/20 0.33
GLO1 Q04760 1/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27503341 0.85 ALDH1A1 (0.41) ALDH1A1TDP1HSD17B10LMNAALOX15
SCHEMBL7672142 0.83 TDP1 (0.42) ALDH1A1TDP1HSD17B10LMNAALOX15
SCHEMBL2454280 0.83 MGAM (0.46) ALDH1A1TDP1HSD17B10LMNAALOX15
Ethane SCHEMBL28133876 0.81 MGAM (0.44) ALDH1A1TDP1HSD17B10LMNAALOX15
SCHEMBL6516731 0.81 ALDH1A1 (0.41) ALDH1A1TDP1HSD17B10LMNAALOX15
SCHEMBL27210229 0.80 ALDH1A1 (0.44) ALDH1A1TDP1GAAMGAMSI
SCHEMBL2303261 0.79 ALDH1A1 (0.43) ALDH1A1TDP1HSD17B10LMNAALOX15
SCHEMBL17617141 0.79 ALDH1A1 (0.43) ALDH1A1TDP1HSD17B10LMNAALOX15
SCHEMBL13575648 0.79 ALDH1A1 (0.43) ALDH1A1TDP1HSD17B10LMNAALOX15
SCHEMBL5614105 0.78 ALDH1A1 (0.34) ALDH1A1TDP1HSD17B10LMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451174-A2 PROCESS FOR THE PREPARATION OF COMPOSITIONS HAVING AN INCREASED AMOUNT OF PHARMACEUTICALLY ACTIVE SALTS OF ROTAMERS SCHERING CORPORATION (US) 2004-09-01 EP disclosed
WO-2003048153-A1 PROCESS FOR THE PREPARATION OF COMPOSITIONS HAVING AN INCREASED AMOUNT OF PHARMACEUTICALLY ACTIVE SALTS OF ROTAMERS SCHERING CORPORATION (US) 2003-06-12 WO disclosed